No Data
Express News | Apellis: New Senior Secured Credit Facility Matures on May 13, 2030
Express News | Apellis Eliminates $366 Million Payment Obligations
Express News | Apellis Pharmaceuticals Refinances Existing Debt With up to $475 Million Non-Dilutive Credit Facility From Sixth Street
Analysts Are Bullish on These Healthcare Stocks: Apellis Pharmaceuticals (APLS), TScan Therapeutics (TCRX)
Analysts Conflicted on These Healthcare Names: Sarepta Therapeutics (SRPT), Nevro Corp (NVRO) and Apellis Pharmaceuticals (APLS)
Apellis Pharmaceuticals(APLS.US) Officer Sells US$3.34 Million in Common Stock
$Apellis Pharmaceuticals(APLS.US)$ Officer Deschatelets Pascal sold 78,907 shares of common stock on May 8, 2024 at an average price of $42.3517 for a total value of $3.34 million.Source: Announcement